New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
05:55 EDTCTSH, CTSHCognizant management to meet with JPMorgan
Meetings to be held in Berwyn/Philadelphia/Princeton on March 7 hosted by JPMorgan.
News For CTSH From The Last 14 Days
Check below for free stories on CTSH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
17:03 EDTCTSHLone Pine Capital reports 5.3% passive stake in Cognizant
Subscribe for More Information
09:00 EDTCTSHHealth Net fundamentals remain favorable, says Susquehanna
Susquehanna said Health Net (HNT) fundamentals remain favorable following meetings with management. The firm cited the company's conservative outlook and the benefit of its back office contract with Cognizant (CTSH) which positions the company well for sustainable earnings growth through 2016. Shares of Health Net remain Positive rated with a $55 price target on the shares.
August 12, 2014
06:00 EDTCTSHStocks with implied volatility below IV index mean; CTSH KMP
Subscribe for More Information
August 7, 2014
10:20 EDTCTSHHigh option volume stocks
Subscribe for More Information
07:49 EDTCTSHCognizant price target lowered to $50 form $58 at UBS
Subscribe for More Information
07:43 EDTCTSHCognizant outlook still positive, says Wells Fargo
Subscribe for More Information
August 6, 2014
14:31 EDTCTSHCognizant shares should be bought on weakness, says William Blair
Subscribe for More Information
10:00 EDTCTSHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:58 EDTCTSHCognizant guidance cut client specific, not market driven, says Wells Fargo
Wells Fargo noted that Cognizant attributed its lowered revenue guidance to weakness in near-term spending at a small group of clients, not to a change in its market opportunity. Wells keeps its Outperform rating on Cognizant, as it does not see a change in the company's long-term prospects, but does expect its stock to struggle in the near term following its Q2 report.
09:48 EDTCTSHCognizant plunges after earnings and outlook
Subscribe for More Information
09:13 EDTCTSHOn The Fly: Pre-market Movers
HIGHER: Fox class A shares (FOXA), up 5.9% after withdrawing proposal to acquire Time Warner (TWX), announcing $6B share repurchase program, reporting quarterly results... MannKind (MNKD), up 1.6% after entering a supply agreement with Amphastar Pharmaceuticals (AMPH)... Criteo (CRTO), up 11.5% after upgraded at Goldman following its better than expected Q2 earnings report. LOWER: Time Warner (TWX), down 13% after earnings, maintaining guidance, bid dropped by Fox... Sprint (S), down 16.5% after naming Marcelo Claure as president and CEO, reportedly dropping pursuit of T-Mobile (TMUS). T-Mobile shares also down 8.5%... Groupon (GRPN), down 18%, downgraded at Wunderlich after the company reported lower than expected Q3 results... Walgreen (WAG), down 15.7% after exercises option to acquire remaining 55% of Alliance Boots, says it will not pursue inversion as part of deal... Shire (SHPG), down 6% after Walgreen announced it would stay located in Chicago and Bloomberg last night reported that the Treasury Department is exploring ways to bypass Congress in an attempt to curb corporate inversions... Cytori Therapeutics (CYTX), down 33% after announcing that it has placed enrollment in the ATHENA and ATHENA II trials on clinical hold. UP AFTER EARNINGS: Enphase Energy (ENPH), up 20%... AOL (AOL), up 5%. DOWN AFTER EARNINGS: Nu Skin (NUS), down 8.5%... Rocket Fuel (FUEL), down 27%... Cognizant (CTSH), down 13%... First Solar (FSLR), down 2.5%... Globus Medical (GMED), down 17%.
08:39 EDTCTSHCognizant downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:07 EDTCTSHCognizant sees FY14 EPS at least $2.54, consensus $2.38
Subscribe for More Information
06:06 EDTCTSHCognizant sees Q3 EPS at least 63c, consensus 60c
Subscribe for More Information
06:05 EDTCTSHCognizant reports Q2 adjusted EPS 66c, consensus 58c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use